Consult this LIVE case on TF TAVI in intermediate risk patient with S3 valve, a 75-year-old female with an aortic stenosis.
Percutaneous treatment of coronary bifurcation lesions is a fast evolving field, with an enormous amount of scientific, clinical and technical data currently available. To keep up-to-date with all this vast material, look here…
Watch the short imaging videos on tricuspid valve repair from "First percutaneous Micra leadless pacemaker implantation and tricuspid valve repair with MitraClip NT for lead associated severe tricuspid regurgitation" by Gilbert H.L.Tang et al.
It is clear that we have reached a crossroads with the new technology which we call the "fully bioresorbable scaffold". Today, the community is somewhat insecure about the future of this new technology which is currently still in its early iterations.